These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 2820683

  • 1. [Evaluation of combined chemotherapy including high-dose cisplatin in the treatment of malignant tumors].
    Zhou JC, Feng FY, Sun Y, Wang QL, Zeng WY, Liu YY.
    Zhonghua Zhong Liu Za Zhi; 1987 Mar; 9(2):136-9. PubMed ID: 2820683
    [Abstract] [Full Text] [Related]

  • 2. [High dose cisplatin combination chemotherapy for advanced breast cancer--a report on 50 cases].
    Zhou JC.
    Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):215-7. PubMed ID: 8261870
    [Abstract] [Full Text] [Related]

  • 3. [Comparision of high dose impulsion and low dose density chemotherapeutic regimens with paclitaxel plus cisplatin in advanced NSCLC].
    Hua XM, Ren XW, Liu FL, Liu Y, Zhang CJ, Li ZJ, Xu L, Liu JY, Liu YG.
    Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):621-5. PubMed ID: 15634526
    [Abstract] [Full Text] [Related]

  • 4. [Comparison of NP and MVP regimen in treatment of advanced non-small cell lung cancer].
    Qiang E, Wang SP, Liu SJ, Yiao J.
    Ai Zheng; 2002 Dec; 21(12):1362-4. PubMed ID: 12520749
    [Abstract] [Full Text] [Related]

  • 5. [Various doses cisplatin combined with multi-drug chemotherapy of malignant solid tumors].
    Wang QL.
    Zhonghua Zhong Liu Za Zhi; 1989 May; 11(3):222-5. PubMed ID: 2612337
    [Abstract] [Full Text] [Related]

  • 6. [Comparison of treatment efficacy of the second and the third generations of chemoradiotherapy regimens containing platinum on advanced non-small cell lung cancer].
    Wang YM, Guo LJ, Li LS, Li P, Zheng J, Li L.
    Ai Zheng; 2005 Dec; 24(12):1514-7. PubMed ID: 16351804
    [Abstract] [Full Text] [Related]

  • 7. [Combination chemotherapy with Taxol and cisplatin for 57 patients with non-small cell lung cancer by intraartery and intravenous infusion].
    Zhao Y, Wang SM, Zhang J.
    Ai Zheng; 2002 Dec; 21(12):1365-7. PubMed ID: 12520750
    [Abstract] [Full Text] [Related]

  • 8. [Prospective randomized study of HMVP, MVP, and HVP regimens in treatment of advanced non-small cell lung cancer].
    Gao JF, Li CS, Zhang BC, Du GZ, Zhang XH, Wang J, Zhu YZ, Ou WL, Yang B.
    Ai Zheng; 2004 Apr; 23(4):435-8. PubMed ID: 15087034
    [Abstract] [Full Text] [Related]

  • 9. [A clinical report of high-dose epirubicin combined with cyclophosphamide and fluorouracil for advanced breast cancer].
    Feng J, Zheng X, Dai A.
    Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):468-70. PubMed ID: 10920949
    [Abstract] [Full Text] [Related]

  • 10. [Mitomycin, vindesine and cisplatin combination therapy in the treatment of advanced non-small cell lung cancer: a report of 108 cases].
    Zhang X, Sun Y, Feng F.
    Zhonghua Zhong Liu Za Zhi; 1999 May; 21(3):220-3. PubMed ID: 11776842
    [Abstract] [Full Text] [Related]

  • 11. Cisplatin and vindesine combination chemotherapy for non-small cell lung cancer: a randomized trial comparing two dosages of cisplatin.
    Shinkai T, Saijo N, Eguchi K, Sasaki Y, Tominaga K, Sakurai M, Suga J, Miyaoka H, Sano T, Keicho N.
    Jpn J Cancer Res; 1986 Aug; 77(8):782-9. PubMed ID: 3019976
    [Abstract] [Full Text] [Related]

  • 12. Do the time to chemotherapy response and the dose intensity have an impact on patient outcome in advanced non-small cell lung cancer?
    Radosavljevic D, Golubicic I, Gavrilovic D, Kezic I, Jelic S.
    J BUON; 2009 Aug; 14(2):203-9. PubMed ID: 19650167
    [Abstract] [Full Text] [Related]

  • 13. [MEP therapy of advanced lung cancer].
    Komuro Y, Ohnishi M, Saitoh A, Morohashi Y.
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2688-91. PubMed ID: 2820313
    [Abstract] [Full Text] [Related]

  • 14. Dose-intense phase II study of weekly cisplatin and epidoxorubicin plus medroxyprogesterone acetate and recombinant interleukin 2 in stage IIIB-IV non-small cell lung cancer.
    Mantovani G, Macciò A, Mulas C, Massa E, Madeddu C, Mura L, Contu P, Versace R.
    Oncol Rep; 2002 Sep; 9(3):661-70. PubMed ID: 11956647
    [Abstract] [Full Text] [Related]

  • 15. Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer.
    Sculier JP, Lafitte JJ, Paesmans M, Thiriaux J, Alexopoulos CG, Baumöhl J, Schmerber J, Koumakis G, Florin MC, Zacharias C, Berghmans T, Mommen P, Ninane V, Klastersky J.
    Br J Cancer; 2000 Nov; 83(9):1128-35. PubMed ID: 11027424
    [Abstract] [Full Text] [Related]

  • 16. Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma: a prospective study.
    Franciosi V, Cocconi G, Michiara M, Di Costanzo F, Fosser V, Tonato M, Carlini P, Boni C, Di Sarra S.
    Cancer; 1999 Apr 01; 85(7):1599-605. PubMed ID: 10193952
    [Abstract] [Full Text] [Related]

  • 17. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
    Recchia F, Sica G, De Filippis S, Rosselli M, Saggio G, Guerriero G, Pompili P, Rea S.
    Anticancer Res; 2000 Apr 01; 20(3B):1985-90. PubMed ID: 10928138
    [Abstract] [Full Text] [Related]

  • 18. [A randomized trial comparing ACF (adriamycin, cyclophosphamide, ftorafur) and ACF/MVMF (mitomycin C, vincristine, methotrexate, ftorafur)--a non-cross-resistant alternating chemotherapy of recurrent and advanced breast cancer].
    Mukaiyama T, Ogawa M, Horikoshi N, Inoue K, Tada A, Ueno K, Yamazaki H, Nakamura T, Ito Y, Inagaki J.
    Gan To Kagaku Ryoho; 1989 Mar 01; 16(3 Pt 1):327-32. PubMed ID: 2494947
    [Abstract] [Full Text] [Related]

  • 19. Glutathione in the prevention of cisplatin induced toxicities. A prospectively randomized pilot trial in patients with head and neck cancer and non small cell lung cancer.
    Schmidinger M, Budinsky AC, Wenzel C, Piribauer M, Brix R, Kautzky M, Oder W, Locker GJ, Zielinski CC, Steger GG.
    Wien Klin Wochenschr; 2000 Jul 28; 112(14):617-23. PubMed ID: 11008323
    [Abstract] [Full Text] [Related]

  • 20. Treatment of advanced non-small cell lung cancer (NSCLC): the "Umbria" cooperative study.
    Crinó L, Darwish S, Corgna E, Meacci ML, Di Costanzo F, Buzzi F, Fornari G, Santi F, Ballatori E, Luccioli L.
    Semin Oncol; 1988 Dec 28; 15(6 Suppl 7):52-5. PubMed ID: 2851180
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.